HOME Top Market Reports Next-Generation Sequencing (NGS) Market by Product (Hiseq, Miseq, Hiseq X Ten/X Five, NextSeq500, Ion Proton, PGM, Ions5, PacBio RSII), Services (Targeted, RNA, Exome, De Novo), & Application (Diagnostics, Biomarker, Agriculture) - Global Forecasts to 2022

Next-Generation Sequencing (NGS) Market by Product (Hiseq, Miseq, Hiseq X Ten/X Five, NextSeq500, Ion Proton, PGM, Ions5, PacBio RSII), Services (Targeted, RNA, Exome, De Novo), & Application (Diagnostics, Biomarker, Agriculture) - Global Forecasts to 2022

By: marketsandmarkets.com
Publishing Date: March 2017
Report Code: BT 2697

 

  Speak to Analyst Enquiry Before Buying Webinar
purchase report
download pdf  request for customisation


The global next-generation sequencing market is projected to reach USD 12.45 Billion by 2022, at a CAGR of 20.5% in the forecast period (2017–2022). Factors such as technological advancements in NGS platforms, increasing applications of NGS, growing partnerships & collaborations, increasing adoption of NGS among research laboratories and academic institutes, and the decline in the cost of sequencing are driving the growth of this market. On the other hand, accuracy and standardization concerns in diagnostic testing and the lack of skilled technical personnel are some of the key factors limiting the growth of the market.

Geographically, the market is segmented into North America, Europe, Asia-Pacific, and the Rest of the World (RoW). North America is estimated to command the largest share of the NGS market in 2017, followed by Europe and Asia-Pacific. Emerging markets, like China, India, and Brazil are expected to offer significant growth opportunities owing to the improving healthcare infrastructure, government funding for translational research, and rising partnerships & agreements among market players. In addition, these countries have less-stringent regulations and data requirements as compared to developed nations; companies find regulatory policies in the Asia-Pacific region to be adaptive and business-friendly. Moreover, increasing competition in mature markets will intensify the focus on emerging markets.

As of 2016, Illumina, Inc. (U.S.), Thermo Fisher Scientific Inc. (U.S.), and Pacific Biosciences of California, Inc. (U.S.), hold the leading position in the global NGS market. In the past three years, these companies adopted product launches & product enhancements, agreements, collaborations, and partnerships as their key business strategies to ensure market dominance. QIAGEN N. V. (Germany), BGI (China), Oxford Nanopore Technologies, Ltd. (U.K.), PerkinElmer, Inc. (U.S.), GATC Biotech AG (Germany), Agilent Technologies, Inc. (U.S.), Roche Holding AG (Switzerland), Macrogen, Inc. (South Korea), and Eurofins Scientific (Luxembourg) are some of the other major players in this market.

Stakeholders

  • NGS Equipment Manufacturers, Vendors, and Distributors
  • NGS Sequencing Services Companies
  • NGS Bioinformatics/Data Analysis Companies
  • Research Institutes and Government Organizations
  • Venture Capitalists and Other Government Funding Organizations
  • Research and Consulting Firms
  • Healthcare Institutions (Hospitals and Medical Schools)
  • Pharmaceutical and Biotechnology Companies
  • Contract Manufacturing Organizations (CMOs)
  • Contract Research Organizations (CROs)

To know about the assumptions considered for the study, download the pdf brochure

Scope of the Report

This report categorizes the global next-generation sequencing (NGS) market into the following segments and subsegments:

Global Next-generation Sequencing (NGS) Market, by Product and Service

  • Pre-sequencing Products and Services Market
    • DNA Fragmentation, End Repair, A-Tailing, and Size Selection
    • Library Preparation & Target Enrichment
    • Quality Control
  • NGS Platforms, Consumables, Reagents, and Services
    • Illumina
      • Hiseq Series
      • Hiseq X Ten & HiSeq X Five
      • Miseq Series
      • NextSeq500
      • MiniSeq
    • Life Technologies (Thermo Fisher Scientific)
      • Ion PGM
      • Ion Proton
      • Ion S5 & S5 XL
    • Pacific Biosciences
      • PacBio RS II
      • Sequel System
    • Oxford Nanopore Technologies
    • Others
    • Recently Launched Sequencing Platforms
  • Sequencing Services Market
    • Targeted Sequencing/Gene Panels
    • RNA-Seq
    • De Novo Sequencing
    • Exome Sequencing
    • CHiP-Seq
    • Whole-genome Sequencing
    • Methyl-Seq
    • Others (amplicon sequencing, epigenomics, digital karyotyping, and metagenomics)
  • NGS Data Analysis, Storage, And Management (Bioinformatics) Market
    • NGS Data Analysis Software & Workbenches
    • NGS Data Analysis Services
    • NGS Storage Management and Cloud Computing Solutions

Global Next-generation Sequencing Market (NGS) Market, by Technology

  • Sequencing by Synthesis (SBS)
  • Ion Semiconductor Sequencing
  • Single-Molecule Real-time (SMRT) Sequencing
  • Nanopore Sequencing

Global Next-generation Sequencing Market (NGS) Market, by Application

  • Diagnostics
  • Drug Discovery
  • Biomarker Discovery
  • Precision Medicine
  • Agriculture and Animal Research
  • Other Applications (Marine Research, Research In Bio-Fuels, Forensic Medicine, and Phylogeographic & Phylogenetic Studies)

Global Next-generation Sequencing Market (NGS) Market, by End User

  • Research Centers, Academic & Government Institutes
  • Hospitals & Clinics
  • Pharmaceutical & Biotechnology Companies
  • Other End-Users (NPOs, Agrigenomics Organizations, and Consumer Genomic Companies)

Global Next-generation Sequencing Market (NGS) Market, by Region

  • North America
  • Europe
  • Asia-Pacific
  • Rest of the World (RoW)

Available Customizations

With the given market data, MarketsandMarkets offers customizations as per the company’s specific needs. The following customization options are available for the report:

Company Information

  • Detailed analysis and profiling of additional market players (up to 5)

Geographic Analysis

Further breakdown of the regional next-generation sequencing market into countries:

  • North America into U.S. and Canada
  • Europe into Germany, France, U.K., and Rest of Europe
  • Asia-Pacific into China, Japan, India, and Rest of Asia-Pacific.

Table of Contents

1 Introduction (Page No. - 17)
    1.1 Objectives of the Study
    1.2 Market Definition
    1.3 Market Scope
           1.3.1 Markets Covered
           1.3.2 Years Considered for the Study
    1.4 Currency
    1.5 Limitations
    1.6 Stakeholders

2 Research Methodology (Page No. - 22)

    2.1 Research Methodology Steps
    2.2 Research Design
    2.3 Secondary and Primary Research Methodology
           2.3.1 Secondary Research
                    2.3.1.1 Key Data From Secondary Sources
           2.3.2 Primary Data
                    2.3.2.1 Breakdown of Primaries
                    2.3.2.2 Key Data From Primary Sources
                    2.3.2.3 Key Industry Insights
    2.4 Market Size Estimation
           2.4.1 Bottom-Up Approach
           2.4.2 Top-Down Approach
    2.5 Market Breakdown and Data Triangulation
    2.6 Assumptions for the Study

3 Executive Summary (Page No. - 32)
    3.1 Introduction

4 Premium Insights (Page No. - 36)
    4.1 Next-Generation Sequencing (NGS): Market Overview
    4.2 NGS Market, By Product & Service (2017 vs 2022)
    4.3 NGS Market Size, By Application, 2017 vs 2022
    4.4 NGS Market, By End User (2017 vs 2022)
    4.5 Geographic Analysis: NGS Market Size, By Product & Service (2017 vs 2022), USD Million

5 Market Overview (Page No. - 40)
    5.1 Introduction
    5.2 Market Dynamics
           5.2.1 Drivers
                    5.2.1.1 Technological Advancements in Sequencing Platforms
                    5.2.1.2 Increasing Applications of NGS
                    5.2.1.3 Growing Number of Partnerships and Collaborations
                    5.2.1.4 Increasing Adoption of NGS Technologies Among Research Laboratories and Academic Institutes
                    5.2.1.5 Conferences and Workshops Increasing Awareness on NGS Products and Services
           5.2.2 Restraints
                    5.2.2.1 Dearth of Skilled Professionals
                    5.2.2.2 Difficulties in Storage of Sequencing Data
           5.2.3 Opportunities
                    5.2.3.1 Government Initiatives in Population Sequencing
                    5.2.3.2 Application of NGS in Precision Medicine & Biomarker Discovery
                    5.2.3.3 Emerging Markets Offer Significant Growth Opportunities
                    5.2.3.4 Cloud Computing, A Prospective Service
           5.2.4 Challenges
                    5.2.4.1 Interpretation of Complex Data From NGS Platforms
                    5.2.4.2 Accuracy & Standardization Concerns in Diagnostic Testing
                    5.2.4.3 Issues Related to the Security of NGS Data
           5.2.5 Industry Trends
                    5.2.5.1 Integration of Next-Generation Sequencing With Cloud-Based Technology
                    5.2.5.2 Focus on Cancer Research
                    5.2.5.3 Mergers and Acquisitions
                    5.2.5.4 Entry of New Market Players

6 Next-Generation Sequencing Market, By Product & Service (Page No. - 53)
    6.1 Introduction
    6.2 Pre-Sequencing Products & Services Market
           6.2.1 Sample Preparation
                    6.2.1.1 Dna Fragmentation, End Repair, A-Tailing, and Size Selection
                    6.2.1.2 Library Preparation & Target Enrichment
                    6.2.1.3 Quality Control
    6.3 NGS Platforms, Consumables, & Services for Platforms
           6.3.1 NGS Platforms Market
                    6.3.1.1 Illumina
                               6.3.1.1.1 Hiseq Series
                               6.3.1.1.2 Hiseq X Ten & Hiseq X Five
                               6.3.1.1.3 Miseq Series
                               6.3.1.1.4 Nextseq 500
                               6.3.1.1.5 Miniseq
                    6.3.1.2 Thermo Fisher Scientific (Life Technologies)
                               6.3.1.2.1 ION PGM
                               6.3.1.2.2 ION Proton
                               6.3.1.2.3 ION S5 & S5 XL
                    6.3.1.3 Pacific Biosciences
                               6.3.1.3.1 Pacbio Rs II
                               6.3.1.3.2 Sequel System
                    6.3.1.4 Oxford Nanopore
                    6.3.1.5 Other Next-Generation Sequencing Platforms
                    6.3.1.6 Recently Launched Sequencing Platforms
    6.4 Sequencing Services Market
           6.4.1 Targeted Re-Sequencing
           6.4.2 Rna-Seq
           6.4.3 De Novo Sequencing
           6.4.4 Exome Sequencing
           6.4.5 Chip-Seq
           6.4.6 Whole-Genome Sequencing
           6.4.7 Methyl-Seq
           6.4.8 Other Applications
    6.5 NGS Data Analysis, Storage, and Management (Bioinformatics)
           6.5.1 NGS Data Analysis Software & Workbenches
           6.5.2 NGS Data Analysis Services
           6.5.3 NGS Storage, Management, and Cloud Computing Solutions

7 Next-Generation Sequencing Market, By Technology (Page No. - 83)
    7.1 Introduction
    7.2 Sequencing By Synthesis
    7.3 ION Semiconductor Sequencing
    7.4 Single-Molecule Real-Time Sequencing
    7.5 Nanopore Sequencing

8 Next-Generation Sequencing Market, By Application (Page No. - 90)
    8.1 Introduction
    8.2 Diagnostics
    8.3 Drug Discovery
    8.4 Biomarker Discovery
    8.5 Precision Medicine
    8.6 Agriculture & Animal Research
    8.7 Other Applications

9 Next-Generation Sequencing Market, By End User (Page No. - 101)
    9.1 Introduction
    9.2 Research Centers and Academic & Government Institutes
    9.3 Hospitals & Clinics
    9.4 Pharmaceutical & Biotechnology Companies
    9.5 Other End Users

10 Next-Generation Sequencing Market, By Region (Page No. - 107)
     10.1 Introduction
     10.2 North America
             10.2.1 U.S.
                        10.2.1.1 Favorable Government Funding Scenario in the U.S. Market
                        10.2.1.2 Growing Focus of NGS Market Players on Strengthening Their Presence in the U.S.
                        10.2.1.3 Increasing Number of NGS Conferences in the U.S.
             10.2.2 Canada
                        10.2.2.1 Favorable Government Funding Scenario in Canada
                        10.2.2.2 Growing Focus of Market Players on Expanding Their Presence in Canada
     10.3 Europe
             10.3.1 Market Players Capitalizing on Opportunities in the European NGS Market
                        10.3.1.1 Launch of New and Advanced Products and Services
                        10.3.1.2 Partnerships/Agreements/Collaborations
             10.3.2 Germany, U.K., and Belgium: Major Hubs for Scientific Research
             10.3.3 Growing Funding and Investments for NGS in Europe
     10.4 Asia-Pacific
             10.4.1 Growing Focus of Domestic and Multinational Players on APAC Market
                        10.4.1.1 Launch of Advanced NGS Products and Services
                        10.4.1.2 Partnerships/Collaborations/Agreements to Co-Develop Advanced NGS Products and Services
             10.4.2 Favorable Government Funding Scenario
             10.4.3 Conferences/Seminars/Training Programs
     10.5 Rest of the World (RoW)
             10.5.1 Focus of Key Market Players on Expanding Their Presence in RoW Countries
             10.5.2 Workshops and Conferences
             10.5.3 Favorable Initiatives By Public and Private Organizations

11 Competitive Landscape (Page No. - 136)
     11.1 Overview
     11.2 Market Share Analysis
     11.3 Competitive Situation and Trends
             11.3.1 Product Launches, Product Enhancements, and Service Launches
             11.3.2 Agreements, Partnerships, Collaborations, and Contracts
             11.3.3 Mergers and Acquisitions
             11.3.4 Expansions
             11.3.5 Other Developments

12 Company Profiles (Page No. - 144)
(Introduction, Products & Services, Strategy, & Analyst Insights, Developments, MnM View)*
     12.1 Introduction
             12.1.1 Geographic Benchmarking
     12.2 Illumina, Inc.
     12.3 Thermo Fisher Scientific Inc.
     12.4 Pacific Biosciences of California, Inc.
     12.5 Qiagen N.V.
     12.6 Beijing Genomics Institute
     12.7 Perkinelmer, Inc.
     12.8 F. Hoffmann-La Roche AG
     12.9 Agilent Technologies, Inc.
     12.10 Gatc Biotech AG
     12.11 Oxford Nanopore Technologies, Ltd.
     12.12 Macrogen, Inc.
     12.13 Eurofins Scientific

*Details on Marketsandmarkets View, Introduction, Product & Services, Strategy, & Analyst Insights, New Developments Might Not Be Captured in Case of Unlisted Companies.

13 Appendix (Page No. - 206)
     13.1 Discussion Guide
     13.2 Knowledge Store: Marketsandmarkets’ Subscription Portal
     13.3 Introducing RT: Real-Time Market Intelligence
     13.4 Available Customizations
     13.5 Related Reports
     13.6 Author Details


List of Tables (96 Tables)

Table 1 List of Sequencing Platforms Launched By Market Players During 2015–2017
Table 2 New Market Players and Their Sequencing Platforms
Table 3 NGS Market Size, By Product & Service, 2015–2022 (USD Million)
Table 4 Pre-Sequencing Products & Services Market Size, By Type, 2015–2022 (USD Million)
Table 5 Pre-Sequencing Products & Services Market Size, By Region, 2015–2022 (USD Million)
Table 6 Dna Fragmentation, End Repair, A-Tailing, & Size Selection Market Size, By Region, 2015–2022 (USD Million)
Table 7 Library Preparation & Target Enrichment Market Size, By Region, 2015–2022 (USD Million)
Table 8 Quality Control Market Size, By Region, 2015–2022 (USD Million)
Table 9 NGS Instruments, Consumables, and Services Market Size, By Type, 2015–2022 (USD Million)
Table 10 NGS Platforms Market Size, By Region, 2015–2022 (USD Million)
Table 11 NGS Consumables Market Size, By Region, 2015–2022 (USD Million)
Table 12 NGS Services for NGS Systems Market Size, By Region, 2015–2022 (USD Million)
Table 13 Illumina NGS Platforms Market Size, By Product, 2015–2022 (USD Million)
Table 14 Illumina NGS Platforms Market Size, By Region, 2015–2022 (USD Million)
Table 15 Hiseq Series Platforms Market Size, By Region, 2015–2022 (USD Million)
Table 16 Hiseq X Ten & Hiseq X Five Platforms Market Size, By Region, 2015–2022 (USD Million)
Table 17 Miseq Series Platforms Market Size, By Region, 2015–2022 (USD Million)
Table 18 Nextseq 500 Platforms Market Size, By Region, 2015–2022 (USD Million)
Table 19 Miniseq Platforms Market Size, By Region, 2015–2022 (USD Million)
Table 20 Thermo Fisher Scientific NGS Platforms Market Size, By Product, 2015–2022 (USD Million)
Table 21 Thermo Fisher Scientific NGS Platforms Market Size, By Region, 2015–2022 (USD Million)
Table 22 ION PGM Platforms Market Size, By Region, 2015–2022 (USD Million)
Table 23 ION Proton Platforms Market Size, By Region, 2015–2022 (USD Million)
Table 24 ION S5 & S5 XL Platforms Market Size, By Region, 2015–2022 (USD Million)
Table 25 Pacific Biosciences NGS Platforms Market Size, By Product, 2015–2022 (USD Million)
Table 26 Pacific Biosciences NGS Platforms Market Size, By Region, 2015–2022 (USD Million)
Table 27 Pacbio Rs II Platforms Market Size, By Region, 2015–2022 (USD Million)
Table 28 Sequel System Market Size, By Region, 2015–2022 (USD Million)
Table 29 Oxford Nanopore NGS Platforms Market Size, By Region, 2015–2022 (USD Million)
Table 30 Other NGS Platforms Market Size, By Region, 2015–2022 (USD Million)
Table 31 Sequencing Services Market Size, By Application, 2015–2022 (USD Million)
Table 32 Sequencing Services Market Size, By Region, 2015–2022 (USD Million)
Table 33 NGS Bioinformatics Market Size, By Product & Service, 2015–2022 (USD Million)
Table 34 NGS Bioinformatics Market Size, By Region, 2015–2022 (USD Million)
Table 35 Data Analysis Software and Workbenches Market Size, By Region, 2015–2022 (USD Million)
Table 36 Data Analysis Services Market Size, By Region, 2015–2022 (USD Million)
Table 37 Next-Generation Sequencing Technologies, By Company
Table 38 Global Next-Generation Sequencing Market Size, By Technology, 2015–2022 (USD Million)
Table 39 Sequencing By Synthesis Market Size, By Region, 2015–2022 (USD Million)
Table 40 ION Semiconductor Sequencing Market Size, By Region, 2015–2022 (USD Million)
Table 41 Single-Molecule Real-Time Sequencing Market Size, By Region, 2015–2022 (USD Million)
Table 42 Nanopore Sequencing Market Size, By Region, 2015–2022 (USD Million)
Table 43 Next-Generation Sequencing Market Size, By Application, 2015–2022 (USD Million)
Table 44 Next-Generation Sequencing Market Size for Diagnostics, By Region, 2015–2022 (USD Million)
Table 45 Next-Generation Sequencing Market Size for Drug Discovery, By Region, 2015–2022 (USD Million)
Table 46 Next-Generation Sequencing Market Size for Biomarker Discovery, By Region, 2015–2022 (USD Million)
Table 47 Next-Generation Sequencing Market Size for Precision Medicine, By Region, 2015–2022 (USD Million)
Table 48 Next-Generation Sequencing Market Size for Agriculture and Animal Research, By Region, 2015–2022 (USD Million)
Table 49 Next-Generation Sequencing Market Size for Other Applications, By Region, 2015–2022 (USD Million)
Table 50 Next-Generation Sequencing Market Size, By End User, 2015–2022 (USD Million)
Table 51 Next-Generation Sequencing Market Size for Research Centers and Academic & Government Institutes, By Region, 2015–2022 (USD Million)
Table 52 Next-Generation Sequencing Market Size for Hospitals & Clinics, By Region, 2015–2022 (USD Million)
Table 53 Next-Generation Sequencing Market Size for Pharmaceutical & Biotechnology Companies, By Region, 2015–2022 (USD Million)
Table 54 Next-Generation Sequencing Market Size for Other End Users, By Region, 2015–2022 (USD Million)
Table 55 NGS Market Size, By Region, 2015–2022 (USD Million)
Table 56 North America: NGS Market Size, By Product & Service, 2015–2022 (USD Million)
Table 57 North America: NGS Pre-Sequencing Products & Services Market Size, By Type, 2015–2022 (USD Million)
Table 58 North America: Illumina NGS Platforms Market Size, By Type, 2015–2022 (USD Million)
Table 59 North America: Thermo Fisher Scientific NGS Platforms Market Size, By Type, 2015–2022 (USD Million)
Table 60 North America: Pacific Biosciences NGS Platforms Market Size, By Type, 2015–2022 (USD Million)
Table 61 North America: NGS Bioinformatics Market Size, By Product & Service, 2015–2022 (USD Million)
Table 62 North America: NGS Market Size, By Technology, 2015–2022 (USD Million)
Table 63 North America: NGS Market Size, By Application, 2015–2022 (USD Million)
Table 64 North America: NGS Market Size, By End User, 2015–2022 (USD Million)
Table 65 Europe: NGS Market Size, By Product & Service, 2015–2022 (USD Million)
Table 66 Europe: NGS Pre-Sequencing Products & Services Market Size, By Type, 2015–2022 (USD Million)
Table 67 Europe: Illumina NGS Platforms Market Size, By Type, 2015–2022 (USD Million)
Table 68 Europe: Thermo Fisher Scientific NGS Platforms Market Size, By Type, 2015–2022 (USD Million)
Table 69 Europe: Pacific Biosciences NGS Platforms Market Size, By Type, 2015–2022 (USD Million)
Table 70 Europe: NGS Bioinformatics Market Size, By Product & Service, 2015–2022 (USD Million)
Table 71 Europe: NGS Market Size, By Technology, 2015–2022 (USD Million)
Table 72 Europe: NGS Market Size, By Application, 2015–2022 (USD Million)
Table 73 Europe: NGS Market Size, By End User, 2015–2022 (USD Million)
Table 74 Asia-Pacific: NGS Market Size, By Product & Service, 2015–2022 (USD Million)
Table 75 Asia-Pacific: NGS Pre-Sequencing Products & Services Market Size, By Type, 2015–2022 (USD Million)
Table 76 Asia-Pacific: Illumina NGS Platforms Market Size, By Type, 2015–2022 (USD Million)
Table 77 Asia-Pacific: Thermo Fisher Scientific NGS Platforms Market Size, By Type, 2015–2022 (USD Million)
Table 78 Asia-Pacific: Pacific Biosciences NGS Platforms Market Size, By Type, 2015–2022 (USD Million)
Table 79 Asia-Pacific: NGS Bioinformatics Market Size, By Product & Service, 2015–2022 (USD Million)
Table 80 Asia-Pacific: NGS Market Size, By Technology, 2015–2022 (USD Million)
Table 81 Asia-Pacific: NGS Market Size, By Application, 2015–2022 (USD Million)
Table 82 Asia-Pacific: NGS Market Size, By End User, 2015–2022 (USD Million)
Table 83 RoW: NGS Market Size, By Product & Service, 2015–2022 (USD Million)
Table 84 RoW: NGS Pre-Sequencing Products & Services Market Size, By Type, 2015–2022 (USD Million)
Table 85 RoW: Illumina NGS Platforms Market Size, By Type, 2015–2022 (USD Million)
Table 86 RoW: Thermo Fisher Scientific NGS Platforms Market Size, By Type, 2015–2022 (USD Million)
Table 87 RoW: Pacific Biosciences NGS Platforms Market Size, By Type, 2015–2022 (USD Million)
Table 88 RoW: NGS Bioinformatics Market Size, By Product & Service, 2015–2022 (USD Million)
Table 89 RoW: NGS Market Size, By Technology, 2015–2022 (USD Million)
Table 90 RoW: NGS Market Size, By Application, 2015–2022 (USD Million)
Table 91 RoW: NGS Market Size, By End User, 2015–2022 (USD Million)
Table 92 Top 5 Product Launches, Product Enhancements, and Service Launches 2016–2017 (January)
Table 93 Top 5 Agreements, Partnerships, Collaborations, and Contracts 2016–2017 (January)
Table 94 Top 5 Mergers and Acquisitions, 2015–2017 (January)
Table 95 Top Geographic Expansions, 2016
Table 96 Top 5 Other Developments, 2015–2017 (January)


List of Figures (35 Figures)

Figure 1 Global Next-Generation Sequencing Market: Research Methodology Steps
Figure 2 Breakdown of Primary Interviews: By Company Type, Designation, and Region
Figure 3 NGS Market: Bottom-Up Approach
Figure 4 NGS Market: Top-Down Approach
Figure 5 NGS Market: Data Triangulation
Figure 6 Global NGS Market, By Application, 2017 vs 2022 (USD Million)
Figure 7 Global NGS Platforms Market, 2017 vs 2022
Figure 8 Global NGS Market, By End User, 2017 vs 2022 (USD Million)
Figure 9 Global NGS Market, By Region, 2016 (USD Million)
Figure 10 NGS Market to Register A High, Double-Digit Growth Rate in the Forecast Period (2017–2022)
Figure 11 Pre-Sequencing Products & Services Segment to Register the Highest CAGR Between 2017 & 2022
Figure 12 Diagnostics Application Will Continue to Dominate the NGS Market in 2022
Figure 13 Research Centers and Academic & Government Institutes to Account for the Largest Share of the NGS Market in 2017
Figure 14 Consumables Will Be the Dominant Product Segment in All Regions
Figure 15 NGS Market: Drivers, Restraints, Opportunities, and Challenges
Figure 16 Nanopore Sequencing to Register the Highest CAGR During 2017 to 2022
Figure 17 Diagnostics Application Segment Will Continue to Dominate the Global Next-Generation Sequencing Market in 2022 (USD Million)
Figure 18 Hospitals & Clinics to Register the Highest CAGR in the Forecast Period
Figure 19 Global NGS Market Overview
Figure 20 North America: NGS Market Snapshot
Figure 21 Europe: NGS Market Snapshot
Figure 22 Asia-Pacific: NGS Market Snapshot
Figure 23 RoW: NGS Market Snapshot
Figure 24 Leading Market Players Adopted Both Organic and Inorganic Growth Strategies Over the Last Three Years (2014 to January, 2017)
Figure 25 Global NGS Platform Market Share Analysis, By Key Player, 2016
Figure 26 Geographic Revenue Mix of the Top Four Market Players* (2016)
Figure 27 Illumina, Inc.: Company Snapshot (2016)
Figure 28 Thermo Fisher Scientific Inc.: Company Snapshot (2016)
Figure 29 Pacific Biosciences of California, Inc.: Company Snapshot (2015)
Figure 30 Qiagen N.V.: Company Snapshot (2016)
Figure 31 Perkinelmer, Inc.: Company Snapshot (2015)
Figure 32 Roche Holding AG: Company Snapshot (2016)
Figure 33 Agilent Technologies, Inc.: Company Snapshot (2016)
Figure 34 Macrogen, Inc.: Company Snapshot (2015)
Figure 35 Eurofins Scientific: Company Snapshot (2016)

The next-generation sequencing market is expected to reach USD 12.45 Billion by 2022 from USD 4.90 Billion in 2017, at a CAGR of 20.5% between 2017 and 2022. Factors such as technological advancements in NGS platforms, increasing applications of NGS, growing partnerships and collaborations, and increasing adoption of NGS among research laboratories and academic institutes are driving the growth of this market. On the other hand, accuracy and standardization concerns in diagnostic testing and the lack of skilled technical personnel are some of the key factors limiting the growth of the market. In addition, storage of sequencing data and interpretation of complex data from NGS platforms are major concerns faced by the sequencing industry.

This report broadly segments the global NGS market into products & services, technology, application, and end user. On the basis of product and service, the NGS market is categorized into pre-sequencing products and services, NGS platforms, consumables, services for platforms, sequencing services, and bioinformatics. In 2017, the consumables segment is expected to account for the largest share of the market.

On the basis of technology, the global NGS market is segmented into sequencing by synthesis (SBS), ion semiconductor sequencing, single-molecule real-time (SMRT) sequencing, and nanopore sequencing. In 2017, the SBS technology is expected to account for the largest share of the market, majorly due to the development of new and advanced NGS platforms, the increasing demand for Illumina’s systems (including the HiSeq series and MiSeq), and the growing demand for NextSeq and HiSeq X Ten.

Based on applications, the market is categorized into six segments, namely, diagnostics, drug discovery, biomarker discovery, precision medicine, agriculture & animal research, and other application. The diagnostics application segment is expected to account for the major share of the global NGS market owing to the increasing focus of key market players on providing & developing NGS-based diagnostic tests and the growing adoption of NGS-based diagnostic tests related to oncology and infectious diseases.

On the basis of end user, the market is segmented into research centers and academic & government institutes, hospitals & clinics, pharmaceutical & biotechnology companies, and other end users. Among these end users, the hospitals and clinics segment is expected to register the highest CAGR due to the growing number of agreements between companies and hospitals for the development of advanced tests and products catering to the specific needs of hospitals and clinics. For instance, in November 2016, Illumina, Inc. entered into an agreement with Mayo Clinic (U.S.) to install its BaseSpace Clarity LIMS in Mayo’s specific laboratories.

This report covers the NGS market across four major geographies, namely, North America, Europe, Asia-Pacific, and the Rest of the World (RoW). Of the four geographic regions studied in the report, North America is expected to command the largest share of the market in 2017. However, Asia-Pacific is expected to register the highest growth rate during the forecast period, due to the improving healthcare infrastructure and favorable government initiatives in this region.

Next-Generation Sequencing (NGS) Market

The major players in the global market are Illumina, Inc. (U.S.), Thermo Fisher Scientific Inc. (U.S.), QIAGEN N. V. (Germany), Pacific Biosciences of California, Inc. (U.S.), BGI (China), Oxford Nanopore Technologies, Ltd. (U.K.), PerkinElmer, Inc. (U.S.), GATC Biotech AG (Germany), Agilent Technologies, Inc. (U.S.), Roche Holding AG (Switzerland), Macrogen, Inc. (South Korea), and Eurofins Scientific (Luxembourg).

To speak to our analyst for a discussion on the above findings, click Speak to Analyst

Available Customizations Title

Client Customization Problem Statement : Global Market Forecasting of NGS Installations

Solution Provided:
In this customization, MnM developed insights beyond the report covering market sizing and forecast of cumulative instal....
In this customization, MnM developed insights beyond the report covering market sizing and forecast of cumulative installation of NGS platforms at regional level. It also focused on finding out locations of NGS platform installation across all major regions. The market was estimated at all levels and was cross validated through primary interviews.
less...
Request Customization
 more...

Client Consult Problem Statement : MnM’s client was interested in the U.S. NGS services market and its sub-segments. Additionally, the client also wanted to understand the guidelines for regulations and payment challenges involved with NGS services in the U.S. along with estimation and forecast of high-growth segments of the market.

Solution Provided:

1. Methodology Adopted by MnM :

Both, top-down and bottom-up approaches were used to de....

1. Methodology Adopted by MnM :

Both, top-down and bottom-up approaches were used to derive the data. MnM utilized authentic secondary sources (government websites, associations and groups, annual reports of companies, SEC filings, corporate presentations) along with MnM Repository to gain insights, both quantitative and qualitative, into the market. MnM then conducted multi-level, qualitative & quantitative study with a constructed sample of mid to senior level management executives and industry professionals to understand key parameters influencing the market.  At every level the estimates were further verified with industry experts.

2. Actual Solution Provided:

   • Identified companies that play major role in providing NGS services 
   • Competitive landscape of companies with existing and estimated market share analysis
   • Identified potential challenges in shipping genome sequencing samples to the U.S.
   • Strategic recommendation related to focused services and market
   • Provided information on guidelines for regulations and payment challenges
   • Analyzed the opportunities in the market for the client by identifying the high-growth segments

Value Delivered:

Client could identify the crucial end-users to enhance its business across the segments and geographies. Additionally, the study helped client to restructure its services pricing, with the current and future price trend.

less...
Request Customization
 more...
Custom Market Research Services

We will customize the research for you, in case the report listed above does not meet with your exact requirements. Our custom research will comprehensively cover the business information you require to help you arrive at strategic and profitable business decisions.

Please visit http://www.marketsandmarkets.com/knowledge-process-outsourcing-services.asp to specify your custom Research Requirement

Connect With Us

Follow us on LinkedIn  Follow us on Facebook   Follow us on Twitter 
Live Chat Support


US : 1-888-600-6441
UK : 44-800-368-9399

Search reports



Access reports on all high
growth Biotechnology Markets on KnowledgeStore
Request Demo